Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01579942 · ClinicalTrials.gov registry record
Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 70
- Enrollment target
NCT01579942: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT01579942 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01579942 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The investigators are doing this study to find out if they can use electroencephalographic (EEG) recordings, which measure brain waves, to predict response to antidepressant treatments, as well as to distinguish patients who have depression from those who do not. In particular the investigators want to test the usefulness of a new type of analysis of EEG recordings called brain network activation or BNA. BNA allows to identify patterns of activation in brain networks and to track their changes over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01579942
The ClinicalTrials.gov registry entry for NCT01579942 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01579942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01579942 about?
NCT01579942 is a clinical study titled "Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression". The investigators are doing this study to find out if they can use electroencephalographic (EEG) recordings, which measure brain waves, to predict response to antidepressant treatments, as well as to distinguish patients who have depression from those who do not. In particular the investigators want...
What is the current status of trial NCT01579942?
This trial is currently terminated. The enrollment target is 70 participants. The study started on 2012-04.
Who is sponsoring clinical trial NCT01579942?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.